薬剤耐性菌に対する126床市中病院における抗菌薬適正使用支援活動の方略と効果

「緒言」近年, 薬剤耐性(antimicrobial resistance: AMR)は環境や人の健康に影響を及ぼす世界的な公衆衛生上の最大の課題の1つとなっている(World Health Organization. 2020 Antibiotic resistance; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance, 2023年9月8日). 医療機関においては, AMRによる感染症により, 入院期間の長期化や病院コストの増大, 死亡率の上昇を招いている...

Full description

Saved in:
Bibliographic Details
Published in医療薬学 Vol. 50; no. 3; pp. 113 - 121
Main Authors 有馬, 隆司, 藤﨑, 崇史, 桑波田, 聡, 竹中, 俊宏, 中村, 聡志, 本屋, 敏郎, 黒木, 優歩, 中島, 隆司, 安水, 里美, 田代, 良一, 愛甲, 隼人, 東, 勇希
Format Journal Article
LanguageJapanese
Published 一般社団法人日本医療薬学会 10.03.2024
日本医療薬学会
Subjects
Online AccessGet full text
ISSN1346-342X
1882-1499
DOI10.5649/jjphcs.50.113

Cover

Abstract 「緒言」近年, 薬剤耐性(antimicrobial resistance: AMR)は環境や人の健康に影響を及ぼす世界的な公衆衛生上の最大の課題の1つとなっている(World Health Organization. 2020 Antibiotic resistance; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance, 2023年9月8日). 医療機関においては, AMRによる感染症により, 入院期間の長期化や病院コストの増大, 死亡率の上昇を招いている. 2016年には米国感染症学会/米国病院疫学学会による抗菌薬管理ガイドラインにおいて, 不適切な抗菌薬の使用を減らし, 抗菌薬の副作用, 菌交代現象, 薬剤耐性菌の出現など抗菌薬使用による意図しない結果を最小限に抑えながら臨床転帰を最適化すること, さらには医療の質に悪影響を与えることなく医療費を削減することを目標とした抗菌薬適正使用支援プログラム(antimicrobial stewardship program: ASP)が提唱された.
AbstractList 「緒言」近年, 薬剤耐性(antimicrobial resistance: AMR)は環境や人の健康に影響を及ぼす世界的な公衆衛生上の最大の課題の1つとなっている(World Health Organization. 2020 Antibiotic resistance; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance, 2023年9月8日). 医療機関においては, AMRによる感染症により, 入院期間の長期化や病院コストの増大, 死亡率の上昇を招いている. 2016年には米国感染症学会/米国病院疫学学会による抗菌薬管理ガイドラインにおいて, 不適切な抗菌薬の使用を減らし, 抗菌薬の副作用, 菌交代現象, 薬剤耐性菌の出現など抗菌薬使用による意図しない結果を最小限に抑えながら臨床転帰を最適化すること, さらには医療の質に悪影響を与えることなく医療費を削減することを目標とした抗菌薬適正使用支援プログラム(antimicrobial stewardship program: ASP)が提唱された.
Author 中島, 隆司
藤﨑, 崇史
本屋, 敏郎
桑波田, 聡
愛甲, 隼人
東, 勇希
中村, 聡志
有馬, 隆司
安水, 里美
竹中, 俊宏
黒木, 優歩
田代, 良一
Author_xml – sequence: 1
  fullname: 有馬, 隆司
  organization: 垂水市立医療センター 垂水中央病院 泌尿器科
– sequence: 1
  fullname: 藤﨑, 崇史
  organization: 垂水市立医療センター 垂水中央病院 薬剤室
– sequence: 1
  fullname: 桑波田, 聡
  organization: 垂水市立医療センター 垂水中央病院 総合診療科・内科
– sequence: 1
  fullname: 竹中, 俊宏
  organization: 垂水市立医療センター 垂水中央病院 総合診療科・内科
– sequence: 1
  fullname: 中村, 聡志
  organization: 垂水市立医療センター 垂水中央病院 薬剤室
– sequence: 1
  fullname: 本屋, 敏郎
  organization: 垂水市立医療センター 垂水中央病院 薬剤室
– sequence: 1
  fullname: 黒木, 優歩
  organization: 垂水市立医療センター 垂水中央病院 薬剤室
– sequence: 1
  fullname: 中島, 隆司
  organization: 垂水市立医療センター 垂水中央病院 薬剤室
– sequence: 1
  fullname: 安水, 里美
  organization: 垂水市立医療センター 垂水中央病院 検査室
– sequence: 1
  fullname: 田代, 良一
  organization: 垂水市立医療センター 垂水中央病院 看護部
– sequence: 1
  fullname: 愛甲, 隼人
  organization: 垂水市立医療センター 垂水中央病院 薬剤室
– sequence: 1
  fullname: 東, 勇希
  organization: 垂水市立医療センター 垂水中央病院 薬剤室
BookMark eNo1UMlKxEAUbETB9ehnZEyv031TxA0ELwrems6mCZnMkOjBmxE8OCOo4IwI4sEFFbeLBxfUj4nJjH9hu12qHtSrKqh-0B1VIxeAYWiWKCNiJAhqy3ZSomYJQtwF-iDnyIBEiG59Y8IMTNBiLxhKEt8yTQwhg1T0gbDTusm3zjrru8X6RWdnO0uv8_u3LD3MNhoQsfy5nj9ufDzetg82Pw9PtJql9Szd02pRP9D_2v6ZXhW3px-v7-39y2L_vth5KB5e8kYzS--K1lO7eZ6ll3n9qTg-GgQ9ngoTd-iPB8DC5MT8-LQxOzc1Mz42awSIcW4ozxGEehzTsmN7yBLQgxhhRqwyc8tEKGYJy1Hcop7WCcKOBzkVrl0WjFDk4QEw9ZtbcR3fVmE1Cv3IlUF1NY50r3QsWltWcUUiExFpmlQPokmfejsNCBJMOKJcJ43-JgXJilpyZS32Kypekype8e1QR_6sLqkp8Td82_8lWzfIQOEvD5ei7g
ContentType Journal Article
Copyright 日本医療薬学会
Copyright_xml – notice: 日本医療薬学会
CorporateAuthor 総合診療科・内科
検査室
看護部
垂水市立医療センター 垂水中央病院 薬剤室
泌尿器科
CorporateAuthor_xml – name: 看護部
– name: 垂水市立医療センター 垂水中央病院 薬剤室
– name: 総合診療科・内科
– name: 泌尿器科
– name: 検査室
DOI 10.5649/jjphcs.50.113
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1882-1499
EndPage 121
ExternalDocumentID db5pharm_2024_005003_004_0113_01214348258
article_jjphcs_50_3_50_113_article_char_ja
GroupedDBID .LE
5GY
ALMA_UNASSIGNED_HOLDINGS
KQ8
MOJWN
RJT
ID FETCH-LOGICAL-j2688-afd945f8357dcf2b91f132364b76e749a6b9bda8b5fdcf423df1859ec796452f3
ISSN 1346-342X
IngestDate Thu Jul 10 16:14:16 EDT 2025
Wed Sep 03 06:30:26 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 3
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2688-afd945f8357dcf2b91f132364b76e749a6b9bda8b5fdcf423df1859ec796452f3
OpenAccessLink https://www.jstage.jst.go.jp/article/jjphcs/50/3/50_113/_article/-char/ja
PageCount 9
ParticipantIDs medicalonline_journals_db5pharm_2024_005003_004_0113_01214348258
jstage_primary_article_jjphcs_50_3_50_113_article_char_ja
PublicationCentury 2000
PublicationDate 2024/03/10
20240310
PublicationDateYYYYMMDD 2024-03-10
PublicationDate_xml – month: 03
  year: 2024
  text: 2024/03/10
  day: 10
PublicationDecade 2020
PublicationTitle 医療薬学
PublicationTitleAlternate 医療薬学
PublicationYear 2024
Publisher 一般社団法人日本医療薬学会
日本医療薬学会
Publisher_xml – name: 一般社団法人日本医療薬学会
– name: 日本医療薬学会
References 10)Mas-Morey P, Valle M, A systematic review of inpatient antimicrobial stewardship programmes involving clinical pharmacists in small-to-mediumsized hospitals, Eur J Hosp Pharm, 2018, 25, e69-e73. doi: 10.1136/ejhpharm-2017-001381.
20)Anderson DJ, Watson S, Moehring RW, Komarow L, Finnemeyer M, Arias RM, Huvane J, Hill CB, Deckard N, Sexton DJ, Feasibility of Core Antimicrobial Stewardship Interventions in Community Hospitals, JAMA Netw Open, 2019, 2, e199369. doi: 10.1001/jamanetworkopen.2019.9369.
9)Tsugita M, Antimicrobial Susceptibility of Pseudomonas aeruginosa Is Improved by Pharmacist’s Intervention in the Use of Antimicrobial Agents, Jpn J Environment Infect, 2012, 27, 285-291.
19)Bantar C, Sartori B, Vesco E, Heft C, Saúl M, Salamone F, Oliva ME, A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance, Clin Infect Dis, 2003, 37, 180-186.
11)Takito S, Kusama Y, Fukuda H, Kutsuna S, Pharmacist-supported antimicrobial stewardship in a retirement home, J Infect Chemother, 2020, 26, 858-861.
6)Akazawa T, Kusama Y, Fukuda H, Hayakawa K, Kutsuna S, Moriyama Y, Ohashi H, Tamura S, Yamamoto K, Hara R, Shigeno A, Ota M, Ishikane M, Tokita S, Terakado H, Ohmagari N, Eight-Year Experience of Antimicrobial Stewardship Program and the Trend of Carbapenem Use at a Tertiary Acute-Care Hospital in Japan—The Impact of Postprescription Review and Feedback, Open Forum Infect Dis, 2019, 6, ofz389. doi: 10.1093/ofid/ofz389.
13)Aldred KJ, Kerns RJ, Osheroff N, Mechanism of quinolone action and resistance, Biochemistry, 2014, 53, 1565-1574.
15)Uda A, Shigemura K, Kitagawa K, Osawa K, Kusuki M, Yan Y, Yano I, Miyara T, Effect of Antimicrobial Stewardship on Oral Quinolone Use and Resistance Patterns over 8 Years (2013–2020), Antibiotics (Basel), 2021, 10, 1426. doi: 10.3390/antibiotics10111426.
4)Yamada K, Imoto W, Yamairi K, Shibata W, Namikawa H, Yoshii N, Fujimoto H, Nakaie K, Okada Y, Fujita A, Kawaguchi H, Shinoda Y, Nakamura Y, Kaneko Y, Yoshida H, Kakeya H, The intervention by an antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gram-negative bacteria, J Infect Chemother, 2019, 25, 1001-1006.
8)Maeda M, Muraki Y, Kosaka T, Yamada T, Aoki Y, Kaku M, Kawaguchi T, Seki M, Tanabe Y, Fujita N, Morita K, Yanagihara K, Yoshida K, Niki Y, The first nationwide survey of antimicrobial stewardship programs conducted by the Japanese Society of Chemotherapy, J Infect Chemother, 2019, 25, 83-88.
2)Roberts RR, Hota B, Ahmad I, Scott RD II, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA, Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship, Clin Infect Dis, 2009, 49, 1175-1184.
21)村木優一, 抗菌薬適正使用支援における薬剤師の役割, YAKUGAKU ZASSHI, 2019, 139, 557-564.
12)Nakamura S, Arima T, Tashiro R, Yasumizu S, Aikou H, Watanabe E, Nakashima T, Nagatomo Y, Kakimoto I, Motoya T, Impact of an antimicrobial stewardship in a 126-bed community hospital with close communication between pharmacists working on post-prescription audit, ward pharmacists, and the antimicrobial stewardship team, J Pharm Health Care Sci, 2021, 7, 25. doi: 10.1186/s40780-021-00206-x.
3)Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, Hamilton CW, Jenkins TC, Lipsett PA, Malani PN, May LS, Moran GJ, Neuhauser MM, Newland JG, Ohl CA, Samore MH, Seo SK, Trivedi KK, Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America, Clin Infect Dis, 2016, 62, e51-77. doi: 10.1093/cid/ciw118.
1)Giske CG, Monnet DL, Cars O, Carmeli Y, Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli, Antimicrob Agents Chemother, 2008, 52, 813-821.
18)村田明子, 川嶋 郁, 畠山英司, 山﨑彩華, 松本勝城, 深沢貴志, 松本菜月, 神谷あかね, 藤田浩之, 擦式アルコール手指消毒薬の使用率向上による細菌分離率の低下, 日本環境感染学会誌, 2020, 35, 163-167.
14)Terahara F, Nishiura H, Fluoroquinolone consumption and Escherichia coli resistance in Japan: an ecological study, BMC Public Health, 2019, 19, 426. doi: 10.1186/s12889-019-6804-3.
17)中村茂樹, MRSAの感染制御, 日本環境感染学会誌, 2022, 37, 217-226.
22)Doernberg SB, Dudas V, Trivedi KK, Implementation of an antimicrobial stewardship program targeting residents with urinary tract infections in three community long-term care facilities: a quasi-experimental study using time-series analysis, Antimicrob Resist Infect Control, 2015, 4, 54. doi: 10.1186/s13756-015-0095-y.
16)Wang H, Wang H, Yu X, Zhou H, Li B, Chen G, Ye Z, Wang Y, Cui X, Zheng Y, Zhao R, Yang H, Wang Z, Wang P, Yang C, Liu L, Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010–2016: a retrospective observational study, BMJ Open, 2019, 9, e026072. doi: 10.1136/bmjopen-2018-026072.
7)Maeda M, Muraki Y, Kosaka T, Yamada T, Aoki Y, Kaku M, Seki M, Tanabe Y, Fujita N, Niki Y, Morita K, Yanagihara K, Yoshida K, Kawaguchi T, Impact of health policy on structural requisites for antimicrobial stewardship: A nationwide survey conducted in Japanese hospitals after enforcing the revised reimbursement system for antimicrobial stewardship programs, J Infect Chemother, 2021, 27, 1-6.
5)Hagiwara D, Sato K, Miyazaki M, Kamada M, Moriwaki N, Nakano T, Shiotsuka S, Tokushige C, Toh H, Kamimura H, Togawa A, Takata T, The impact of earlier intervention by an antimicrobial stewardship team for specific antimicrobials in a single weekly intervention, Int J Infect Dis, 2018, 77, 34-39.
References_xml – reference: 16)Wang H, Wang H, Yu X, Zhou H, Li B, Chen G, Ye Z, Wang Y, Cui X, Zheng Y, Zhao R, Yang H, Wang Z, Wang P, Yang C, Liu L, Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010–2016: a retrospective observational study, BMJ Open, 2019, 9, e026072. doi: 10.1136/bmjopen-2018-026072.
– reference: 8)Maeda M, Muraki Y, Kosaka T, Yamada T, Aoki Y, Kaku M, Kawaguchi T, Seki M, Tanabe Y, Fujita N, Morita K, Yanagihara K, Yoshida K, Niki Y, The first nationwide survey of antimicrobial stewardship programs conducted by the Japanese Society of Chemotherapy, J Infect Chemother, 2019, 25, 83-88.
– reference: 7)Maeda M, Muraki Y, Kosaka T, Yamada T, Aoki Y, Kaku M, Seki M, Tanabe Y, Fujita N, Niki Y, Morita K, Yanagihara K, Yoshida K, Kawaguchi T, Impact of health policy on structural requisites for antimicrobial stewardship: A nationwide survey conducted in Japanese hospitals after enforcing the revised reimbursement system for antimicrobial stewardship programs, J Infect Chemother, 2021, 27, 1-6.
– reference: 2)Roberts RR, Hota B, Ahmad I, Scott RD II, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA, Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship, Clin Infect Dis, 2009, 49, 1175-1184.
– reference: 12)Nakamura S, Arima T, Tashiro R, Yasumizu S, Aikou H, Watanabe E, Nakashima T, Nagatomo Y, Kakimoto I, Motoya T, Impact of an antimicrobial stewardship in a 126-bed community hospital with close communication between pharmacists working on post-prescription audit, ward pharmacists, and the antimicrobial stewardship team, J Pharm Health Care Sci, 2021, 7, 25. doi: 10.1186/s40780-021-00206-x.
– reference: 3)Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, Hamilton CW, Jenkins TC, Lipsett PA, Malani PN, May LS, Moran GJ, Neuhauser MM, Newland JG, Ohl CA, Samore MH, Seo SK, Trivedi KK, Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America, Clin Infect Dis, 2016, 62, e51-77. doi: 10.1093/cid/ciw118.
– reference: 15)Uda A, Shigemura K, Kitagawa K, Osawa K, Kusuki M, Yan Y, Yano I, Miyara T, Effect of Antimicrobial Stewardship on Oral Quinolone Use and Resistance Patterns over 8 Years (2013–2020), Antibiotics (Basel), 2021, 10, 1426. doi: 10.3390/antibiotics10111426.
– reference: 17)中村茂樹, MRSAの感染制御, 日本環境感染学会誌, 2022, 37, 217-226.
– reference: 1)Giske CG, Monnet DL, Cars O, Carmeli Y, Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli, Antimicrob Agents Chemother, 2008, 52, 813-821.
– reference: 11)Takito S, Kusama Y, Fukuda H, Kutsuna S, Pharmacist-supported antimicrobial stewardship in a retirement home, J Infect Chemother, 2020, 26, 858-861.
– reference: 20)Anderson DJ, Watson S, Moehring RW, Komarow L, Finnemeyer M, Arias RM, Huvane J, Hill CB, Deckard N, Sexton DJ, Feasibility of Core Antimicrobial Stewardship Interventions in Community Hospitals, JAMA Netw Open, 2019, 2, e199369. doi: 10.1001/jamanetworkopen.2019.9369.
– reference: 6)Akazawa T, Kusama Y, Fukuda H, Hayakawa K, Kutsuna S, Moriyama Y, Ohashi H, Tamura S, Yamamoto K, Hara R, Shigeno A, Ota M, Ishikane M, Tokita S, Terakado H, Ohmagari N, Eight-Year Experience of Antimicrobial Stewardship Program and the Trend of Carbapenem Use at a Tertiary Acute-Care Hospital in Japan—The Impact of Postprescription Review and Feedback, Open Forum Infect Dis, 2019, 6, ofz389. doi: 10.1093/ofid/ofz389.
– reference: 4)Yamada K, Imoto W, Yamairi K, Shibata W, Namikawa H, Yoshii N, Fujimoto H, Nakaie K, Okada Y, Fujita A, Kawaguchi H, Shinoda Y, Nakamura Y, Kaneko Y, Yoshida H, Kakeya H, The intervention by an antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gram-negative bacteria, J Infect Chemother, 2019, 25, 1001-1006.
– reference: 5)Hagiwara D, Sato K, Miyazaki M, Kamada M, Moriwaki N, Nakano T, Shiotsuka S, Tokushige C, Toh H, Kamimura H, Togawa A, Takata T, The impact of earlier intervention by an antimicrobial stewardship team for specific antimicrobials in a single weekly intervention, Int J Infect Dis, 2018, 77, 34-39.
– reference: 9)Tsugita M, Antimicrobial Susceptibility of Pseudomonas aeruginosa Is Improved by Pharmacist’s Intervention in the Use of Antimicrobial Agents, Jpn J Environment Infect, 2012, 27, 285-291.
– reference: 14)Terahara F, Nishiura H, Fluoroquinolone consumption and Escherichia coli resistance in Japan: an ecological study, BMC Public Health, 2019, 19, 426. doi: 10.1186/s12889-019-6804-3.
– reference: 21)村木優一, 抗菌薬適正使用支援における薬剤師の役割, YAKUGAKU ZASSHI, 2019, 139, 557-564.
– reference: 18)村田明子, 川嶋 郁, 畠山英司, 山﨑彩華, 松本勝城, 深沢貴志, 松本菜月, 神谷あかね, 藤田浩之, 擦式アルコール手指消毒薬の使用率向上による細菌分離率の低下, 日本環境感染学会誌, 2020, 35, 163-167.
– reference: 19)Bantar C, Sartori B, Vesco E, Heft C, Saúl M, Salamone F, Oliva ME, A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance, Clin Infect Dis, 2003, 37, 180-186.
– reference: 10)Mas-Morey P, Valle M, A systematic review of inpatient antimicrobial stewardship programmes involving clinical pharmacists in small-to-mediumsized hospitals, Eur J Hosp Pharm, 2018, 25, e69-e73. doi: 10.1136/ejhpharm-2017-001381.
– reference: 13)Aldred KJ, Kerns RJ, Osheroff N, Mechanism of quinolone action and resistance, Biochemistry, 2014, 53, 1565-1574.
– reference: 22)Doernberg SB, Dudas V, Trivedi KK, Implementation of an antimicrobial stewardship program targeting residents with urinary tract infections in three community long-term care facilities: a quasi-experimental study using time-series analysis, Antimicrob Resist Infect Control, 2015, 4, 54. doi: 10.1186/s13756-015-0095-y.
SSID ssib003116159
ssib002484604
ssib000871962
ssib060196744
ssj0069027
ssib005902156
ssib023157658
Score 2.3470938
Snippet 「緒言」近年, 薬剤耐性(antimicrobial resistance: AMR)は環境や人の健康に影響を及ぼす世界的な公衆衛生上の最大の課題の1つとなっている(World Health Organization. 2020 Antibiotic resistance; 2020. Available from:...
SourceID medicalonline
jstage
SourceType Publisher
StartPage 113
SubjectTerms antimicrobial resistance
antimicrobial stewardship
antimicrobial use density
levofloxacin
pharmaceutical care
post-prescription audits
Title 薬剤耐性菌に対する126床市中病院における抗菌薬適正使用支援活動の方略と効果
URI https://www.jstage.jst.go.jp/article/jjphcs/50/3/50_113/_article/-char/ja
http://mol.medicalonline.jp/library/journal/download?GoodsID=db5pharm/2024/005003/004&name=0113-0121j
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 医療薬学, 2024/03/10, Vol.50(3), pp.113-121
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LThRBcIJ4MTHGZ8RX9mBzYnHn3X1zZpkN0WgwgYTbZJ4xG0UicMATS-JBMEETHiExHnxEjCIXDqBRP2bZBX7As1U1szODMRH10tvpqq6ux_R01Wx3tSRdVTw_NnyYSJEs_LLmmZjyNjDKwvAqUWxUIh7hAedbt43BEe3GqD7adeRHYdfS1KTfHzz67bmSf7EqtIFd8ZTsX1g2IwoNUAf7QgkWhvJQNmYOZ8JgVpU5OuOCWRq20N4F5hhYsUxqqTEOOCq4jcyyEdmqMdtJW4SgisK4jVcxAtS2GLeowrHd0bBiDTDHZMJkXGeOwF6WUqBJFeyV0JQzmsSJhR1zTjK2BXUXiAP0LZXGGmB2jcbSmMURhJUa0QG2NaxAaZMgQF_oHTYcQgaooO4gZgbihGwRCHAcJqpFv5ygVaJpomgodUG3yFv2CbOgD6A0QLJyGkQmndWYMHNcQKmibUBUqyOzAP2SolEenuOSyHaFBrBJG5zMWkuH5JUcV0dxOUkDPVArwLVJ2jXRttwpftBRtDLtDsymIDFmkoKIw_QZ-oMKiI8q8F9Yy1TNKKsa3VafLXZJlt90UquFlUtOjgSnTpCcHFv_dX3VDQ3T09br43eDiX6dbgTKHYlse2fo6-OYeN1F8VxMMVRR4QeqgO9iFkENcyrp_Ih0VDFN2l5x804xLDBhYSiktZMxLimkmRPoqWZuNIQoEDXn_-4bmPOJbnVIPDID0OmSpY5Ckly7KMy1A6KAF1qHmAyTbRy_n_xPmuSrKbicwyelE2msWLKSiX9K6qp7p6XeoSTZ_HRfaTg_OznRV-otDeVp6KfPSPf2lj-2nrzZm3nWnnm3t_C02fjQ2vjWbKw2Z-dhnrc-z7W2Zne21ndXHu-vvgJoszHXbDwHaHtuBfCh-37jfXv99c7X77uLa-3FjfbCZnvzS2t-qdn41F7e3l1622ystea22y9fnJVGas5wdbCc3q1SrisGvEa9OBSaHkP8ZYZBrPhCjmUVL5PwTSMyNeEZvvBDj_t6DHCIucIYPHsRBXh0XVdi9ZzUPfZgLDovldAJDjTfE7EXagE3eAgkvMiUAy2MAy73SCLRqjueJNBx0xemmyjf1SuuigU-HB0Qnjl1616PdP2AIdz07TvhHvoZu_D_JC5Kx_KJeknqnnw4FV2GWGTSv0IP7k-bIwR_
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%96%AC%E5%89%A4%E8%80%90%E6%80%A7%E8%8F%8C%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8B126%E5%BA%8A%E5%B8%82%E4%B8%AD%E7%97%85%E9%99%A2%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E6%8A%97%E8%8F%8C%E8%96%AC%E9%81%A9%E6%AD%A3%E4%BD%BF%E7%94%A8%E6%94%AF%E6%8F%B4%E6%B4%BB%E5%8B%95%E3%81%AE%E6%96%B9%E7%95%A5%E3%81%A8%E5%8A%B9%E6%9E%9C&rft.jtitle=%E5%8C%BB%E7%99%82%E8%96%AC%E5%AD%A6&rft.au=%E4%B8%AD%E6%9D%91%E8%81%A1%E5%BF%97&rft.au=%E6%9C%89%E9%A6%AC%E9%9A%86%E5%8F%B8&rft.au=%E7%94%B0%E4%BB%A3%E8%89%AF%E4%B8%80&rft.au=%E5%AE%89%E6%B0%B4%E9%87%8C%E7%BE%8E&rft.date=2024-03-10&rft.pub=%E6%97%A5%E6%9C%AC%E5%8C%BB%E7%99%82%E8%96%AC%E5%AD%A6%E4%BC%9A&rft.issn=1346-342X&rft.volume=50&rft.issue=3&rft.spage=113&rft.epage=121&rft_id=info:doi/10.5649%2Fjjphcs.50.113&rft.externalDocID=db5pharm_2024_005003_004_0113_01214348258
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-342X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-342X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-342X&client=summon